Anastrozole: tested in a combination
122 studies: another drug in the study is under test too. Page 2 of 2. Open to participants first (22), then studies with results posted, then the rest; newest registration first within each.
- ATAC - Endometrial Sub-ProtocolCompletedNCT00814125Phase 3How we knowReport a problem
- ATAC - Bone Density Sub-ProtocolCompletedNCT00784940Phase 3How we knowReport a problem
- ATAC - Pharmacokinetics (PK) Sub-ProtocolCompletedNCT00784862Phase 3How we knowReport a problem
- ATAC - Quality of Life Sub-ProtocolCompletedNCT00784680Phase 3How we knowReport a problem
- Pre-operative Hormonal Treatment for Hormone Receptor Positive Breast CancerSuspendedNCT00738777Phase 2How we knowReport a problem
- Regulation of Cortisol Metabolism and Fat PatterningStatus unknownNCT00694733Not applicableHow we knowReport a problem
- Fulvestrant With or Without Lapatinib and/or Aromatase Inhibitor Therapy in Treating Postmenopausal Women With Metastatic Breast Cancer That Progressed After Previous Aromatase Inhibitor TherapyStatus unknownNCT00688194Phase 3How we knowReport a problem
- Cyclophosphamide, Methotrexate, and Prednisolone With or Without Aromatase Inhibitor Therapy in Treating Postmenopausal Women With Metastatic Breast CancerStatus unknownNCT00687648Phase 2How we knowReport a problem
- Efficacy of Anastrozole and Fulvestrant in Patients With ER Positive, HER2 Negative, Operable Breast CancerCompletedNCT00629616Phase 2How we knowReport a problem
- Study of Anastrozole, Letrozole, or Exemestane With or Without Tamoxifen in Treating Postmenopausal Women With Hormone-Responsive Breast Cancer That Has Been Completely Removed By SurgeryStatus unknownNCT00541086Phase 3How we knowReport a problem
- Effect of Increasing Testosterone on Insulin Sensitivity in Men With the Metabolic SyndromeTerminatedNCT00438321Phase 1How we knowReport a problem
- Antiestrogen vs Aromatase Inhibitor After Adjuvant Chemotherapy for Breast CancerTerminatedNCT00437359Phase 2How we knowReport a problem
- Insulin Sensitivity in Men With the Metabolic SyndromeSuspendedNCT00433173Not applicableHow we knowReport a problem
- Testosterone Effects on Men With the Metabolic SyndromeWithdrawnNCT00382057Phase 2How we knowReport a problem
- Testosterone-Driven Growth-Hormone (GH) Secretion in Aging MenCompletedNCT00309855Phase 1How we knowReport a problem
- ABCSG 8 - Adjuvant Treatment in Patients With Hormone Receptor-positive Breast Cancer With Good to Moderate Differentiation.CompletedNCT00291759Phase 3How we knowReport a problem
- Use of Arimidex and Zoladex as Pretreatment to IVF in Women With Ovarian EndometriosisCompletedNCT00286351Phase 4How we knowReport a problem
- Study on Pre-menopausal Patients With Advanced ER and PR + BC Treated With Arimidex Plus ZoladexCompletedNCT00235937Phase 2How we knowReport a problem
- PROACT - Pre-Operative Arimidex Compared To TamoxifenCompletedNCT00232661Phase 3How we knowReport a problem
- S0511, Goserelin and Anastrozole in Treating Men With Recurrent or Metastatic Breast CancerWithdrawnNCT00217659Phase 2How we knowReport a problem
- Iressa (ZD1839) Plus Anastrozole (Arimidex) in Patients With Ovarian CancerCompletedNCT00181688Phase 2How we knowReport a problem
- STARS Breast Trial (Study of Anastrozole and Radiotherapy Sequencing Pilot)Status unknownNCT00126360Phase 4How we knowReport a problem